SSG Capital Advisors served as the investment banker to Eiger BioPharmaceuticals, Inc. in the sale of Lonafarnib and Lambda, and associated clinical assets to Eiger InnoTherapeutics, Inc. The sale was effectuated through a Chapter 11 Section 363...
Read Story
September 13, 2024, 07:47 AM
|
SSG Capital Advisors served as the investment banker to Eiger BioPharmaceuticals, Inc. in the sale of Avexitide and its related clinical assets to Amylyx Pharmaceuticals, Inc. The sale was effectuated through a Chapter 11 Section 363 process in the U...
Read Story
July 18, 2024, 07:54 AM
|
SSG Capital Advisors served as the investment banker to Eiger BioPharmaceuticals, Inc. in the sale of substantially all of its assets related to the FDA-approved drug Zokinvy®, to Sentynl Therapeutics, Inc. The sale was effectuated through a Chapter...
Read Story
May 13, 2024, 08:05 AM
|